πŸ’Š Schedule 1 Drugs Are Not All Bad πŸ’‰πŸ§ͺ

β€œSchedule 1 drugs have no medical value and high potential for abuse” – DEA

So they say.

Some examples of Schedule 1 drugs are: Marijuana, Heroin, LSD, Ecstasy, and Magic Mushrooms.

Several pioneering scientists such as William Richards, a psychologist at the Psychiatry Department of the Johns Hopkins University School of Medicine, argue that this claim is widely inaccurate and blinded by propaganda from the government several decades ago.

Such decoupling is understandable. When heroin, ecstasy (MDMA) and LSD were first synthesized in 1874, 1914 and 1930, respectively, little was known about their real effects, but their devastating consequences quickly revealed i.e. addiction and overdosing.

Why are drugs are so dangerous?

Simply put; because of their addictive properties and highly potent effects.

But, that is not all.

Typically schedule 1 drugs found on the streets, expose the user to additional risks. The user would rarely know the quality of the drug, the exact concentration of the active compound, nor what other contaminants are in the drug.

The drugs are often diluted with flour, sugar, starch, painkillers, baking soda, and in some reported cases with crushed glass, cement, brick dust and stones.

The user is exposed to even greater risks than the inherent risks of using or abusing any of the unprescribed and illegal drugs.

Because of the dangers and negative connotations schedule one drugs carry, the average person might be dismissive of any positive medical treatment involving any of these drugs.

It is not to confuse – schedule one drugs are dangerous – if you do not know what you are doing or know exactly what you are taking.

However, if administered properly they may have several medicinal benefits.

There is mounting evidence to suggest that some schedule one drugs could offer effective treatment for depression, anxiety, PTSD and addictions to other substances, such as tobacco in cigarettes, and alcohol.

If schedule one drugs were to be prescribed and administered to patients in controlled environments by highly skilled specialists, who would monitor the dosage and intake of the pharma-grade compound, wouldn’t that make an enormous difference?

Wuhan is exploring this opportunity through upcoming clinical trials and stressing the significance of treating several mental health issues with wrongfully labeled drugs.

 

Luka Marjanovic

Chief Analyst

Luka holds a Bachelor’s in International Business from Denmark and a Master’s in International Management from ESADE. During his undergraduate studies he founded his own consulting firm, providing services to local businesses in various sectors; as well as working as a research assistant in the field of Big Data. Prior to his education he served in the Danish Royal Army as Second Sergeant, leading and managing a group of men, under extreme pressures and conditions. Luka has spent significant time abroad, living and working in six different countries.

No Comments Yet

Comments are closed